• Appeals Court Decision Affirms Patent Protection for LIVALO americanpharmaceuticalreview
    January 11, 2019
    Kowa Pharmaceuticals America announced the U.S. Court of Appeals for the Federal Circuit has affirmed the decision by the U.S. District Court for the Southern District of New York, upholding the validity of U.S. Patent No. 8,557,993....
  • Cadila settles patent litigation related to Livalo tabs expressbpd
    January 18, 2017
    Under the terms of the agreement, Kowa and Nissan grant Zydus a licence to market Zydus’ generic version of Livalo beginning on May 2, 2023, or earlier under certain circumstances
PharmaSources Customer Service